Distinct mutational drug resistance profiles of HIV-1 RNA in plasma and culture isolates of patients receiving antiretroviral therapy

Intervirology

Volumn 45, Issue 1, 2002, Pages 52-55

  Debiaggi, Maurizia ^a,b   Bruno, Raffaele ^a   Sacchi, Paolo ^a   Achilli, Giorgio ^a   Romero, Egidio ^a   Filice, Gaetano ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

Antiretroviral resistance; Antiretroviral therapy; Genotypic assay; HIV; Phenotypic assay

Indexed keywords

ANTIRETROVIRUS AGENT; PROTEINASE; VIRUS DNA;

ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; DNA SEQUENCE; DRUG RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS CULTURE; VIRUS GENE; VIRUS ISOLATION; VIRUS MUTATION;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DRUG RESISTANCE, VIRAL; GENOTYPE; HIV INFECTIONS; HIV PROTEASE; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; LEUKOCYTES, MONONUCLEAR; MUTATION; PHENOTYPE; RNA, VIRAL;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0036218617     PISSN: 03005526     EISSN: None     Source Type: Journal    
DOI: 10.1159/000050087     Document Type: Article

References (15)

1. Human immunodeficiency virus drug resistance testing: State of the art in genotypic and phenotypic testing of antiretrovirals
2. Standardized peripheral blood mononuclear cell assay for determination of drug susceptibilities of clinical human immunodeficiency virus type 1 isolates
3. Recombinant virus assay: A rapid, phenotypic assay for assessment of drug susceptibility of human immunodeficiency virus type 1 isolates
4. Quantitative evaluation of the recombinant HIV-1 phenotype to protease inhibitors by a single-step strategy
5. Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations
6. Human immunodeficiency virus type 1 envelope gene structure and diversity in vivo and after cocultivation in vitro
7. Replicative fitness of protease inhibitor-resistant mutants of human immunodeficiency type 1
8. Zidovudine-resistant human immunodeficiency virus type 1 genomes detected in plasma distinct from viral genomes in peripheral blood mononuclear cells
9. Comparison of human immunodeficiency virus type 1 (HIV-1) protease mutations in HIV-1 genomes detected in plasma and in peripheral blood mononuclear cells from patients receiving combination drug therapy
10. Resistance mutations in protease and reverse transcriptase genes of human immunodeficiency virus type 1 isolates from patients with combination antiretroviral therapy failure
11. NIH/NIAID/DAIDS/ACTG Virology Laboratories: Standardization of sensitive human immune deficiency virus coculture procedures and establishment of a multicenter quality assurance program for the AIDS Clinical Trials Group
12. Drug resistance. An updated user-friendly guide to genotype interpretation
13. A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1
14. Relative replicative fitness of zidovudine-resistant human immunodeficiency virus type 1 isolates in vitro
15. Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV infected patients with detectable viremia